Killer Cells Manufacturers, Suppliers & Companies
-
Technologybased in Carlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Chimeric - Model CHM 0201 (CORE-NK PLATFORM) - Natural Killer Cells
The CORE-NK platform is a transformative platform technology for Chimeric enabling the accelerated development of multiple next generation, off the shelf NK and CAR-NK products. Natural killer cells are found in our ...
CONTACT SUPPLIER -
Technologybased in Paris, FRANCE
The mission of Alderaan Biotechnology is to develop novel therapies to treat cancer by targeting cells from the immune system. Alderaan Biotechnology programs are related to the elimination of Regulatory T cells and to the hyper activation of ...
Model CD160TM - Natural Killer Cells
CD160TM NK cell boost using CD160-TM specific monoclonal antibodies. Natural Killer cells (NK) represents a cell population involved in the cancer cell destruction ...
CONTACT SUPPLIER -
Manufacturerbased in Munich, GERMANY
multimmune GmbH is a private, clinical-stage biopharmaceutical company which has developed a unique and proprietary technology platform for the development and clinical delivery of new cancer therapies on the basis of the founding scientists' ...
multimmune - Model ENKASTIM - Natural Killer (NK) Cells
ENKASTIM is based on the activation of immune cells called natural killer (NK) cells that are major players in the body's first line of defense, also called innate immunity. The immune effector ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
Nkarta - Allogeneic Natural Killer Cells
Cell therapy, a new approach that uses immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. First generation approaches have focused on T-cells, ...
CONTACT SUPPLIER -
Technologybased in Wien, AUSTRIA
BlueSky Immunotherapies GmbH (Ltd.) is a clinical-stage biotech company. The company’s business is based on its own proprietary, novel technology platform for interferon-inducing viral vectors (delNS). Interferons have immunostimulatory and ...
BlueSky - Interferon-inducing Viral Vectors (delNS)
The high level of interferon induced by the delNS vector activates immunological defence reactions against cancer. It also stimulates the production of antiviral ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Off-the-Shelf Natural Killer (NK) Cells for Oncology
Natural Killer (NK) cells are essential components of the immune system, playing an important role in the body’s defensive response against tumors and infected cells. NK cells ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
Alphageneron Pharmaceuticals is a clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer cells (NK) cell and antibody-based therapies to treat cancer. Our seasoned team of biopharmaceutical executives, ...
Membrane Hsp70: Novel Biomarker
Our lead clinical stage natural killer (NK) cell therapy, is an autologous platform technology that activates NK cells to kill cancers expressing a unique membrane form of Heat Shock Protein 70 ...
CONTACT SUPPLIER -
Manufacturerbased in Dartmouth, NOVA SCOTIA (CANADA)
We Advance Novel Immunotherapies for Hard-to-Treat Cancers. IMV Inc. is a clinical-stage pharmaceutical company that has the potential to make history by developing a first-in-class effective T cell-targeted immune therapy for cancer. We have built ...
IMV - Model Maveropepimut-S (DPX-Survivac) - Generating Cancer-Targeted Killer T Cells
Maveropepimut-S (DPX-Survivac) combines the advantages of the DPX platform and the cancer antigen survivin, is the lead candidate of IMV’s new class of immunotherapies that generates cancer-targeted T cells in ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT516 - Natural Killer (NK) Cell
NK cells play a major role in the anti-tumor efficacy of certain tumor-antigen targeting antibodies. NK cells express CD16, an activating receptor that binds to the Fc portion of IgG antibodies. Once activated ...
CONTACT SUPPLIER -
Manufacturerbased in Notting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
-
Manufacturerbased in Florham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CYNK-001 - Placental-derived Natural Killer (PNK) Cells
CYNK-001 is the only cryopreserved, allogeneic, off-the-shelf, natural killer (NK) cell therapy being developed from placental hematopoietic stem cells as a potential treatment option for various ...
CONTACT SUPPLIER -
Manufacturerbased in Freiburg, GERMANY
Sartorius CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. We develop, manufacture and market human cytokines, growth factors, and other ...
CellGenix - Model GMP SCGM - Growth Medium Serum-Free Stem Cell
CellGenix GMP SCGM is an optimized, xeno-free medium used for the serum-free expansion of low numbers of isolated human hematopoietic stem and progenitor cells (HSCs/CD34+ cells). In addition, our SCGM is proved to ...
CONTACT SUPPLIER -
Technologybased in Vienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
-
Manufacturerbased in Shoreview, MINNESOTA (USA)
Delivering breakthrough technology to transform diagnosis and treatment. Our mission is to enable the first point of contact in the healthcare system to immediately identify sepsis and other medical conditions, and to facilitate the most appropriate ...
Ativa - Diagnostic Workstation
Ativa's Diagnostic Workstation with a miniaturized flow-cytometer can measure the innate immune response cells in the blood. In COVID-19, Natural-Killer Cell activation occurs within hours of first ...
CONTACT SUPPLIER -
Manufacturerbased in Pleasanton, CALIFORNIA (USA)
29 years designing high affinity antibodies and immunoassays. Proudly serving the brightest minds in scientific research. Your experts in offering state-of-the-art ELISA kits, antibodies, custom reagents and analytical services in immunology, ...
Model KIR3DP1 (NM_001015070) - Human Over-Expression Lysate
Lysate Of Over-Expression Cell Lines, WB Control. Transient overexpression lysate of killer-cell Ig-like receptor ...
CONTACT SUPPLIER -
Manufacturerbased in Mont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
Celyad - Model CYAD-101 - Allogeneic CAR T Candidate
CYAD-101 is an investigational, non-gene edited allogeneic (from healthy donor derived) CAR T candidate engineered to co-express the chimeric antigen receptor based on NKG2D, a receptor expressed on natural killer (NK) ...
CONTACT SUPPLIER -
Manufacturerbased in Amsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
NK-Cell Therapy
Ushering in the Future of NK-cell Therapy: Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the ...
CONTACT SUPPLIER -
Manufacturerbased in Newark, DELAWARE (USA)
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across ...
ACROBiosystems - Model IL-15 - GMP Grade Cytokines Protein
IL-15,Interleukin-15,IL15,Interleukin ...
CONTACT SUPPLIER -
Manufacturerbased in Tokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
iPSC - Regenerative Medicine
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various ...
CONTACT SUPPLIER -
Manufacturerbased in Norcross, GEORGIA (US) (USA)
Caprico Biotechnologies, Inc. (CBI) was founded in 2013 by a group of experienced scientists with broad clinical and basic research experience in chemistry, molecular biology, and immunology. We are committed to providing a range of flow cytometry ...
Model Anti-HLA-DR APC-Cyanine7 - Mouse Monoclonal Antibody
The clone L243, a mouse monoclonal antibody, recognizes a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain known as human HLA-DR antigen. HLA-DR is widely expressed ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you